Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001367644-22-000089
Filing Date
2022-05-31
Accepted
2022-05-31 16:15:19
Documents
1
Period of Report
2022-05-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165402808228714.html 4  
1 FORM 4 wf-form4_165402808228714.xml 4 3571
  Complete submission text file 0001367644-22-000089.txt   4904
Mailing Address
Business Address
SULLIVAN LOUIS W (Reporting) CIK: 0001193522 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33137 | Film No.: 22983398

Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations